Page last updated: 2024-10-23

bisoprolol and Left Ventricular Outflow Obstruction

bisoprolol has been researched along with Left Ventricular Outflow Obstruction in 6 studies

Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.

Research Excerpts

ExcerptRelevanceReference
"Treatment with bisoprolol was well-tolerated and effective in relieving obstruction and improving symptoms in a significant proportion of patients with symptomatic obstructive HCM."1.72Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study. ( Caiazza, M; Calabrò, P; Cirillo, A; Dongiglio, F; Franco, F; Fusco, A; Limongelli, G; Lioncino, M; Mazzella, M; Monda, E; Moscarella, E; Pacileo, G; Palmiero, G; Rubino, M; Sepe, J; Verrillo, F, 2022)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Monda, E1
Lioncino, M1
Palmiero, G1
Franco, F1
Rubino, M1
Cirillo, A1
Verrillo, F1
Fusco, A1
Caiazza, M1
Mazzella, M1
Moscarella, E1
Dongiglio, F1
Sepe, J1
Pacileo, G1
Calabrò, P1
Limongelli, G1
Minami, Y1
Hagiwara, N1
Nistri, S1
Olivotto, I1
Maron, MS1
Ferrantini, C1
Coppini, R1
Grifoni, C1
Baldini, K1
Sgalambro, A1
Cecchi, F1
Maron, BJ1
Cabrera-Bueno, F1
García-Pinilla, JM1
Gómez-Doblas, JJ1
Montiel-Trujillo, A1
Rodríguez-Bailón, I1
de Teresa-Galván, E1
Watt, J1
Hogg, KJ1
Danton, M1
Kondo, I1
Mizushige, K1
Nozaki, S1
Iwado, Y1
Masugata, H1
Kohno, M1
Matsuo, H1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy[NCT04133532]Phase 422 participants (Actual)Interventional2020-03-05Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for bisoprolol and Left Ventricular Outflow Obstruction

ArticleYear
Beta-blocker therapy for dynamic left ventricular outflow tract obstruction induced by exercise.
    International journal of cardiology, 2007, Apr-25, Volume: 117, Issue:2

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Bisoprolol; Cardiomyopathy, Hypertrophic; Echocardiogr

2007

Other Studies

5 other studies available for bisoprolol and Left Ventricular Outflow Obstruction

ArticleYear
Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study.
    International journal of cardiology, 2022, May-01, Volume: 354

    Topics: Adult; Bisoprolol; Cardiomyopathy, Hypertrophic; Disopyramide; Humans; Retrospective Studies; Ventri

2022
Pharmacological Strategies for Midventricular Obstruction in Patients with Hypertrophic Cardiomyopathy.
    Internal medicine (Tokyo, Japan), 2019, 02-15, Volume: 58, Issue:4

    Topics: Aneurysm; Bisoprolol; Cardiomyopathy, Hypertrophic; Humans; Ventricular Outflow Obstruction; Ventric

2019
β Blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy.
    The American journal of cardiology, 2012, Sep-01, Volume: 110, Issue:5

    Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Cardiomyopathy, Hypertrophic; Cohort Studies; Confid

2012
Resolution of dynamic left ventricular outflow tract obstruction caused by retained native leaflets following mitral valve replacement using medical treatment.
    Heart (British Cardiac Society), 2006, Volume: 92, Issue:9

    Topics: Aged; Bisoprolol; Cardiotonic Agents; Echocardiography; Female; Heart Valve Prosthesis; Heart Valve

2006
Effect of cibenzoline, a class ia antiarrhythmic agent, on left ventricular diastolic function in hypertrophic cardiomyopathy.
    Cardiovascular drugs and therapy, 2001, Volume: 15, Issue:5

    Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Bisoprolol; Blood Flow Velocity; Cardiomyopathy,

2001